|
|
![]() |
|
Structural Studies of Rio2, an Atypical Serine Kinase Required for Ribosome Biogenesis
The RIO kinases are interesting molecules for several reasons. They are ancient essential proteins, and it has been suggested that they represent an evolutionary link between prokaryotic lipid kinases and eukaryotic protein kinases (ePKs). They are very divergent in sequence from known protein kinases and lack many of the sequence features required for the function of ePKs. They are rRNA processing factors with kinase activity and, thus, are attractive potential targets for therapeutic intervention. To understand the nature of these enzymes and their relationships to ePKs, we determined the X-ray crystal structure of Rio2 from Archaeoglobus fulgidus, a hyperthermophilic archaeal organism. Despite a lack of significant sequence homology to ePKs, the RIO catalytic domain bears striking structural homology to the canonical kinase domain (Figure 1). The catalytic domain of kinases such as protein kinase A (PKA) contains 11 subdomains. The catalytic domains of members of the RIO kinase family contain only eight, and these subdomains contain variations that produce differences in phosphate binding, and perhaps substrate recognition and catalysis as well. The most significant difference is the complete absence of subdomain VIII, which is known as the APE (Ala-Pro-Glu), or activation loop. In ePKs, the APE loop is often phosphorylated to regulate the activity of the kinase and provides much of the surface for binding to substrate peptide. The lack of this region in the catalytic domain of Rio2 and other RIO kinases leaves open the question of how RIO kinases bind their substrates. In addition, we found that the N-terminal Rio2specific domain adopts a winged helix fold, which is commonly used by proteins for nucleic acid interactions. Figure 1. The structure of atypical serine kinase Rio2. A ribbon illustration of the three-dimensional structure of the Rio2-ATP-Mn complex showing the secondary structure elements and the various domains. DFG, Asp-Phe-Gly. Our studies provided a detailed description of the ATP-binding pocket of the Rio2 proteins. To determine the mode of ATP binding for the Rio2 kinase, we soaked crystals of the Rio2 protein in a solution containing an ATP analog, AMPPNP, and Mn2+ ions. Divalent cations are known to be required for catalytic activity, and RIO kinases retain the metal-binding residues. Although we were able to observe AMPPNP bound in the active site, we did not find any metal ions. We therefore concluded that the conformation of the complex was not a productive one, and that the confines of the crystal did not allow for the conformational changes required for proper binding of ATP and metal ions. More recent studies confirmed this conclusion. Crystals of the Rio2-ATP-Mn2+ complex assembled before crystallization contain the ATP molecule as well as two Mn2+ ions in the active site. We now know that ATP binds in the RIO kinase domains in a conformation that is different from canonical ePKs. Due to this difference, the γ-phosphate is located in a position that would require further conformational changes in the Rio2 protein for substrate access. These findings support our conclusion that the peptide substrate binding by RIO kinases must differ significantly from that of canonical serine kinases. Because the RIO kinases lack the classical peptide substratebinding loops and bind ATP in a distinct conformation, it is likely that their inhibitors will be very distinct from the inhibitors of classical protein kinases. Our investigations should be helpful in guiding the efforts to develop such inhibitors, based on the structures of the enzymes from each RIO subfamily with bound nucleotides, as well as on the planned structural studies of their complexes with peptides. These discoveries have implications for the role of RIO proteins in rRNA cleavage and provide a framework for experiments to determine their target and function. In addition, this work defines, in structural terms, a novel family of atypical protein serine kinases. |
|